Source link : https://newshealth.biz/health-news/nice-expands-cladribine-access-for-ms-patients/
The National Institute for Health and Care Excellence (NICE) has recommended c ladribine (Mavenclad, Merck Serono) for adults in England with relapsing-remitting multiple sclerosis (RRMS). This decision makes the NHS the first healthcare system in Europe to widely offer the at-home tablet for patients with active MS. The final draft guidance means cladribine is an option […]
The post NICE Expands Cladribine Access for MS Patients first appeared on News Health.
Author : News Health
Publish date : 2025-03-12 19:08:00
Copyright for syndicated content belongs to the linked Source.